Patients with chronic migraine treated with eptinezumab reported improvements in brain fog and the number of good days per month in a real-world setting

Authors
Category Primary study
ConferenceAmerican Headache Society 66th Annual Scientific Meeting
Year 2024
This article has no abstract
Epistemonikos ID: e4324b395ceda3fade16142361582bb87aca9beb
First added on: Jan 10, 2026